CLASSYS Inc
CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used … Read more
CLASSYS Inc (214150) - Net Assets
Latest net assets as of September 2025: ₩518.35 Billion KRW
Based on the latest financial reports, CLASSYS Inc (214150) has net assets worth ₩518.35 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩654.40 Billion) and total liabilities (₩136.05 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩518.35 Billion |
| % of Total Assets | 79.21% |
| Annual Growth Rate | 51.88% |
| 5-Year Change | 265.75% |
| 10-Year Change | N/A |
| Growth Volatility | 63.27 |
CLASSYS Inc - Net Assets Trend (2015–2024)
This chart illustrates how CLASSYS Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CLASSYS Inc (2015–2024)
The table below shows the annual net assets of CLASSYS Inc from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩452.64 Billion | +59.66% |
| 2023-12-31 | ₩283.50 Billion | +23.50% |
| 2022-12-31 | ₩229.55 Billion | +40.19% |
| 2021-12-31 | ₩163.74 Billion | +32.31% |
| 2020-12-31 | ₩123.76 Billion | +40.77% |
| 2019-12-31 | ₩87.92 Billion | +72.24% |
| 2018-12-31 | ₩51.04 Billion | +45.46% |
| 2017-12-31 | ₩35.09 Billion | +231.18% |
| 2016-12-31 | ₩10.60 Billion | +0.77% |
| 2015-12-31 | ₩10.52 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to CLASSYS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 527780.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩336.06 Billion | 74.03% |
| Common Stock | ₩6.63 Billion | 1.46% |
| Other Components | ₩111.28 Billion | 24.51% |
| Total Equity | ₩453.96 Billion | 100.00% |
CLASSYS Inc Competitors by Market Cap
The table below lists competitors of CLASSYS Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Petrosea Tbk
JK:PTRO
|
$817.49 Million |
|
Neinor Homes S.A
PINK:NNRHF
|
$817.63 Million |
|
SRG Global Ltd
AU:SRG
|
$818.10 Million |
|
Jiangsu HHCK Advanced Materials Co. Ltd. A
SHG:688535
|
$818.27 Million |
|
MODEC Inc
PINK:MDIKF
|
$817.40 Million |
|
Sigdo Koppers
SN:SK
|
$817.19 Million |
|
Qt Group Oyj
PINK:QTGPF
|
$817.19 Million |
|
Reit 1 Ltd
PINK:RETDF
|
$816.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CLASSYS Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 283,500,499,660 to 453,964,808,470, a change of 170,464,308,810 (60.1%).
- Net income of 97,875,278,360 contributed positively to equity growth.
- Dividend payments of 12,799,903,800 reduced retained earnings.
- Share repurchases of 29,901,300 reduced equity.
- Other factors increased equity by 85,418,835,550.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩97.88 Billion | +21.56% |
| Dividends Paid | ₩12.80 Billion | -2.82% |
| Share Repurchases | ₩29.90 Million | -0.01% |
| Other Changes | ₩85.42 Billion | +18.82% |
| Total Change | ₩- | 60.13% |
Book Value vs Market Value Analysis
This analysis compares CLASSYS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 27.15x to 7.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1926.57 | ₩52300.00 | x |
| 2017-12-31 | ₩580.29 | ₩52300.00 | x |
| 2018-12-31 | ₩823.63 | ₩52300.00 | x |
| 2019-12-31 | ₩1365.92 | ₩52300.00 | x |
| 2020-12-31 | ₩1912.51 | ₩52300.00 | x |
| 2021-12-31 | ₩2530.17 | ₩52300.00 | x |
| 2022-12-31 | ₩3564.00 | ₩52300.00 | x |
| 2023-12-31 | ₩4421.78 | ₩52300.00 | x |
| 2024-12-31 | ₩6930.56 | ₩52300.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CLASSYS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.56%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 40.29%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.34x
- Recent ROE (21.56%) is above the historical average (19.20%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.61% | 0.00% | 0.00x | 1.13x | ₩-987.87 Million |
| 2016 | 0.76% | 0.30% | 2.27x | 1.13x | ₩-978.77 Million |
| 2017 | -14.61% | -14.71% | 0.55x | 1.80x | ₩-8.64 Billion |
| 2018 | 29.12% | 31.30% | 0.63x | 1.48x | ₩9.76 Billion |
| 2019 | 37.98% | 41.16% | 0.71x | 1.29x | ₩24.60 Billion |
| 2020 | 30.84% | 49.91% | 0.56x | 1.11x | ₩25.79 Billion |
| 2021 | 26.75% | 43.54% | 0.46x | 1.32x | ₩27.43 Billion |
| 2022 | 32.84% | 53.16% | 0.43x | 1.44x | ₩52.42 Billion |
| 2023 | 26.18% | 41.21% | 0.48x | 1.32x | ₩45.88 Billion |
| 2024 | 21.56% | 40.29% | 0.40x | 1.34x | ₩52.48 Billion |
Industry Comparison
This section compares CLASSYS Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CLASSYS Inc (214150) | ₩518.35 Billion | 0.61% | 0.26x | $817.43 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |